User profiles for Ruslan Sergienko

Ruslan Sergienko

Department of Health Policy and Management, Faculty of Health Sciences, Ben-Gurion …
Verified email at bgu.ac.il
Cited by 6762

[HTML][HTML] BNT162b2 vaccine booster and mortality due to Covid-19

R Arbel, A Hammerman, R Sergienko… - … England Journal of …, 2021 - Mass Medical Soc
Background The emergence of the B.1.617.2 (delta) variant of severe acute respiratory
syndrome coronavirus 2 and the reduced effectiveness over time of the BNT162b2 vaccine (Pfizer…

[HTML][HTML] Nirmatrelvir use and severe Covid-19 outcomes during the Omicron surge

…, E Battat, G Lavie, R Sergienko… - … England Journal of …, 2022 - Mass Medical Soc
Background The oral protease inhibitor nirmatrelvir has shown substantial efficacy in high-risk,
unvaccinated patients infected with the B.1.617.2 (delta) variant of severe acute …

[HTML][HTML] Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years

R Arbel, R Sergienko, M Friger, A Peretz… - Nature medicine, 2022 - nature.com
The rapid emergence of the B.1.1.529 (Omicron) variant of SARS-CoV-2 led to a global
resurgence of coronavirus disease 2019 (COVID-19). Israeli authorities approved a fourth COVID…

Critical analysis of risk factors and outcome of placenta previa

T Rosenberg, G Pariente, R Sergienko… - Archives of gynecology …, 2011 - Springer
Objective To investigate risk factors and pregnancy outcome of patients with placenta previa.
Methods A population-based study comparing all singleton pregnancies of women with …

Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study

R Arbel, A Peretz, R Sergienko, M Friger… - The Lancet Infectious …, 2023 - thelancet.com
Background In late 2022, the SARS-CoV-2 omicron (B.1.1.529) BA.5 sublineage accounted
for most of the sequenced viral genomes worldwide. Bivalent mRNA vaccines contain an …

[HTML][HTML] Effectiveness of the BNT162b2 vaccine after recovery from Covid-19

A Hammerman, R Sergienko, M Friger… - … England Journal of …, 2022 - Mass Medical Soc
Background The risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
decreases substantially among patients who have recovered from coronavirus …

Prenatal maternal COVID-19 vaccination and pregnancy outcomes

T Wainstock, I Yoles, R Sergienko, E Sheiner - Vaccine, 2021 - Elsevier
Background Prenatal maternal physiological changes may cause severe COVID-19 among
pregnant women. The Pfizer-BioNTech COVID-19 vaccine (BNT162b2 mRNA) has been …

Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births

T Eshkoli, AY Weintraub, R Sergienko… - American journal of …, 2013 - Elsevier
OBJECTIVE: We sought to evaluate risk factors and perinatal outcomes of pregnancies
complicated with placenta accreta and to study perinatal outcomes in subsequent pregnancies. …

Acute antepartum pyelonephritis in pregnancy: a critical analysis of risk factors and outcomes

E Farkash, AY Weintraub, R Sergienko… - European Journal of …, 2012 - Elsevier
OBJECTIVE: To test the incidence and sonographic parameters of pyelonephritis during
pregnancy, and to examine risk factors and pregnancy outcomes of women with acute …

Prenatal exposure to gestational diabetes mellitus as an independent risk factor for long-term neuropsychiatric morbidity of the offspring

…, H Abokaf, E Spiegel, R Sergienko… - American journal of …, 2016 - Elsevier
Background The reported rates of gestational diabetes mellitus are constantly escalating
and little is known about long-term complications in the offspring. Evidence from the field of …